Dx dialogues: blood-based biomarkers and other diagnostic tools for Alzheimer's and related dementias
Dx dialogues: disease-modifying therapies for Alzheimer's and the hope for a cure
Dx dialogues: considerations when deciding whether to initiate pharmacologic interventions for patients with AD
Dx dialogues: novel approaches in development for the treatment of AD
Dx dialogues: how AI can be integrated in the management of AD
What do neurodegenerative diseases have in common?
How is Alzheimer's disease different from memory loss due to aging?
What do you know about dementia and Alzheimer's disease that you didn't know before?
Dx dialogues: why early intervention is critical in managing tardive dyskinesia
Are Parkinson's patients more susceptible to Alzheimer's?
Learn about other related brain disorders that interfere with cognitive function.
People younger than age 65 can develop Alzheimer's disease—and symptoms are often overlooked.
It mimics Parkinson’s disease but is a very different condition.
An overview of TTR stabilizers and gene-silencing therapies for treating hereditary transthyretin (hATTR) amyloidosis.
Find out why cynical people may be more likely to develop dementia.